Abiomed, Inc. (ABMD) Tops Q2 Views; Reaffirms FY12 Outlook
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Abiomed, Inc. (NASDAQ: ABMD) reported Q2 EPS of $0.09, $0.18 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $27.7 million.
The stock was halted to report the results.
The stock was halted to report the results.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- KB Home (KBH) Tops Q3 EPS by 16c
- Digital Brands Group reports 221% revenue growth for its AVO brand
Create E-mail Alert Related Categories
Earnings, Guidance, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
